The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis
- PMID: 36282189
- DOI: 10.1177/17474930221137019
The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis
Abstract
Background: Cerebral small vessel disease (cSVD) is a major cause of stroke and dementia. Previous studies on the prevalence of cSVD are mostly based on single geographically defined cohorts in high-income countries. Studies investigating the prevalence of cSVD in low- and middle-income countries (LMICs) are expanding but have not been systematically assessed.
Aim: This study aims to systematically review the prevalence of cSVD in LMICs.
Results: Articles were searched from the Ovid MEDLINE and EMBASE databases from 1 January 2000 to 31 March 2022, without language restrictions. Title/abstract screening, full-text review, and data extraction were performed by two to seven independent reviewers. The prevalence of cSVD and study sample size were extracted by pre-defined world regions and health status. The Risk of Bias for Non-randomized Studies tool was used. The protocol was registered on PROSPERO (CRD42022311133). A meta-analysis of proportion was performed to assess the prevalence of different magnetic resonance imaging markers of cSVD, and a meta-regression was performed to investigate associations between cSVD prevalence and type of study, age, and male: female ratio. Of 2743 studies identified, 42 studies spanning 12 global regions were included in the systematic review. Most of the identified studies were from China (n = 23). The median prevalence of moderate-to-severe white matter hyperintensities (WMHs) was 20.5%, 40.5%, and 58.4% in the community, stroke, and dementia groups, respectively. The median prevalence of lacunes was 0.8% and 33.5% in the community and stroke groups. The median prevalence of cerebral microbleeds (CMBs) was 10.7% and 22.4% in the community and stroke groups. The median prevalence of moderate-to-severe perivascular spaces was 25.0% in the community. Meta-regression analyses showed that the weighted median age (51.4 ± 0.0 years old; range: 36.3-80.2) was a significant predictor of the prevalence of moderate-to-severe WMH and lacunes, while the type of study was a significant predictor of the prevalence of CMB. The heterogeneity of studies was high (>95%). Male participants were overrepresented.
Conclusions: This systematic review and meta-analysis provide data on cSVD prevalence in LMICs and demonstrated the high prevalence of the condition. cSVD research in LMICs is being published at an increasing rate, especially between 2010 and 2022. More data are particularly needed from Sub-Saharan Africa and Central Europe, Eastern Europe, and Central Asia.
Keywords: Cerebral small vessel disease; cerebral microbleed; lacunes; low- and middle-income countries; meta-analysis; perivascular space; prevalence; systematic review; white matter hyperintensities.
Similar articles
-
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2. Cochrane Database Syst Rev. 2022. PMID: 35833913 Free PMC article.
-
Association of Mean Upper Cervical Spinal Cord Cross-Sectional Area With Cerebral Small Vessel Disease: A Community-Based Cohort Study.Stroke. 2024 Mar;55(3):687-695. doi: 10.1161/STROKEAHA.123.044666. Epub 2024 Jan 25. Stroke. 2024. PMID: 38269540
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis.J Neurol. 2024 Feb;271(2):772-781. doi: 10.1007/s00415-023-12094-2. Epub 2023 Nov 29. J Neurol. 2024. PMID: 38019295 Free PMC article.
-
Reliability and validity of the total cerebral small vessel disease score: a systematic review and meta-analysis.Front Neurol. 2025 Jun 27;16:1593402. doi: 10.3389/fneur.2025.1593402. eCollection 2025. Front Neurol. 2025. PMID: 40656982 Free PMC article.
Cited by
-
Umbelliferone as an effective component of Rhodiola for protecting the cerebral microvascular endothelial barrier in cSVD.Front Pharmacol. 2025 Mar 17;16:1552579. doi: 10.3389/fphar.2025.1552579. eCollection 2025. Front Pharmacol. 2025. PMID: 40166460 Free PMC article.
-
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment.Physiol Rev. 2025 Jul 1;105(3):1075-1171. doi: 10.1152/physrev.00028.2024. Epub 2025 Feb 18. Physiol Rev. 2025. PMID: 39965059 Free PMC article. Review.
-
Ceramide in cerebrovascular diseases.Front Cell Neurosci. 2023 Jun 2;17:1191609. doi: 10.3389/fncel.2023.1191609. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37333888 Free PMC article. Review.
-
Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health.Expert Rev Neurother. 2024 Jan-Jun;24(1):25-44. doi: 10.1080/14737175.2023.2273393. Epub 2024 Jan 8. Expert Rev Neurother. 2024. PMID: 37916306 Free PMC article. Review.
-
Causal association between cerebral small vessel disease and epilepsy.Neurosurg Rev. 2025 Feb 15;48(1):238. doi: 10.1007/s10143-025-03299-2. Neurosurg Rev. 2025. PMID: 39954159
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical